Valeant Pharmaceuticals International News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.01.17	Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors (PR Newswire)
12.12.16	Valeant Appoints William D. Humphries As EVP, Dermatology (PR Newswire)
08.12.16	Valeant Pharmaceuticals Announces Phase 3 Results For Psoriasis Treatment IDP-118 (PR Newswire)
08.12.16	Pharming Announces Completion of Acquisition of All North American Commercialisation Rights for RUCONEST® From Valeant (PR Newswire)
07.12.16	Valeant Pharmaceuticals trade offers a 13.12% return in 226 days, or find similar option trades on Francesca's Holdings Company, Panera Bread Company, General Electric, and Intel (PR Newswire)
07.12.16	Pharming Announces Completion Of Financing for RUCONEST® North American Rights Acquisition (PR Newswire)
05.12.16	Research Reports Initiation on Healthcare Stocks -- Valeant Pharma, Akorn, Universal Health Services, and LifePoint Health (PR Newswire)
29.11.16	Valeant Announces The Initiation Of A Primary Care Sales Force For Xifaxan® And Relistor® (PR Newswire)
22.11.16	InvestorsObserver releases covered-call reports for Exelixis, Valeant Pharmaceuticals, Cheniere Energy, General Electric and The Kroger Co (PR Newswire)
22.11.16	Pharming Launches Rights Issue to Raise €12.1 Million as Part of RUCONEST® North American Rights Acquisition Financing (PR Newswire)
21.11.16	Pharming Announces Financing Plans for Closing of RUCONEST® North American Rights Acquisition (PR Newswire)
20.07.16	SCLN Withdraws From Auction Block, ZFGN Tumbles, Double Blessing For VRX (RTTNews)
20.07.16	Valeant : FDA Oks RELISTOR Tablets To Treat Opioid-induced Constipation (RTTNews)
10.06.16	Valeant Pharma Considering Sale Of Egypt Drugmaker Amoun: Bloomberg (RTTNews)
06.01.16	WSJ : Valeant Plans To Appoint New CEO As Pearson Remains Hospitalized (RTTNews)
06.10.15	Valeant Receives U.S. Antitrust Approval To Buy Synergetics USA (RTTNews)
22.09.15	Bausch + Lomb And Nicox Say FDA Accepts For Review NDA For VESNEO - Quick Facts (RTTNews)
02.09.15	Valeant To Buy Synergetics For $6.50 Per Share In Cash (RTTNews)
21.08.15	AGN To Face FDA In Q1-2016, DPRX Moves One Step Ahead, RPTP, VRX Open Wallets (RTTNews)
17.07.15	Valeant To Buy Mercury (Cayman) For About US$800 Mln, Plus Contingent Payments (RTTNews)
23.06.15	Valeant Pharma Announces Submission Of U.S. NDA For Oral RELISTOR - Quick Facts (RTTNews)
11.06.15	Valeant Pharma Appoints Robert Rosiello As CFO - Quick Facts (RTTNews)
03.06.15	Nicox: Vesneo, AC-170 On Track For NDA Submission In US - Quick Facts (RTTNews)
29.04.15	Valeant Pharma Swings To Profit In Q1, Projects Improved Results In FY15 (RTTNews)
24.04.15	Valeant Pharma : RELISTOR Gets Positive CHMP Opinion In EU - Quick Facts (RTTNews)
01.04.15	Valeant Closes $11 Bln. Acquisition Of Salix (RTTNews)
13.03.15	Valeant Places Third Largest High-Yield Bond Offering Ever: Report (RTTNews)
24.02.15	BMY, VRX Open Wallet, LLY Does It Again, RIGL Gets A Regal Touch, TRIB Is Back (RTTNews)
23.02.15	Valeant Pharmaceuticals Q4 Net Loss Widens (RTTNews)
23.02.15	Valeant To Buy Salix Pharma In Deal Worth $14.5 Bln (RTTNews)
22.02.15	Reports: Valeant Nears Deal To Buy Salix Pharma For About $10 Bln (RTTNews)
11.02.15	Dendreon Announces Expiration Of Bid Deadline On Deal To Sell Assets To Valeant (RTTNews)
04.02.15	Valeant Pharma In Talks To Buy Salix Pharma: Report (RTTNews)
30.01.15	Valeant Selected As Lead Bidder To Buy PROVENGE Rights, Certain Dendreon Assets (RTTNews)
26.11.14	Psoriasis Drug Trial Meets Goals, Reimbursement Rate For Cologuard Finalized (RTTNews)
21.11.14	Valeant Says May Repurchase Up To $2 Bln Of Securities (RTTNews)
17.11.14	Valeant Pharma Buys Nicox In $20 Mln Deal - Quick Facts (RTTNews)
17.11.14	Reports: Actavis Nears Deal To Acquire Allergan (RTTNews)
12.11.14	Actavis Reportedly In Talks To Buy Allergan For At Least $60 Bln (RTTNews)
04.11.14	Allergan Says Approached By Another Party Regarding A Potential Transaction (RTTNews)
20.10.14	Valeant Pharma Turns To Profit In Q3, Lifts 2014 Earnings Outlook (RTTNews)
20.10.14	Valeant Pharma Turns To Profit In Q3 - Quick Facts (RTTNews)
20.10.14	Earnings Watch For October 20 (AAPL, IBM, TXN, HAL, RMBS) (RTTNews)
09.10.14	Allergan Lifts Q3, 2014 Adj. EPS View - Quick Facts (RTTNews)
03.10.14	Salix Pharma Ends Cosmo Deal; Stock Up On Reports Of Talks For Sale To Actavis (RTTNews)
02.10.14	Proxy Firm ISS Urges Allergan For Shareholder Vote (RTTNews)
01.10.14	Ackman's Pershing Square Raises More Than $3 Bln In Amsterdam IPO (RTTNews)
30.09.14	Valeant's Bridgewater Location Gets FDA Warning Letter (RTTNews)
29.09.14	Allergan Says Its Conclusion On Valeant's Offer Remains Unchanged - Quick Facts (RTTNews)
26.09.14	Bausch + Lomb's Phase 3 Sub-Micron Ophthalmic Gel Trial Meets Primary Endpoint (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Valeant Pharmaceuticals International Inc.

Aktien Top/Flop

Meistgelesene Nachrichten